BTU Signs Licensing Agreement with DuPont for Use of Catalytic Oxidation Technology

BTU International, Inc. (Nasdaq: BTUI), a leading supplier of advanced thermal processing equipment and processes for the alternative energy and electronics manufacturing markets, today announced the signing of a worldwide licensing agreement with DuPont Packaging Graphics (DuPont) for the use of catalytic oxidation technology.

Developed by DuPont Packaging Graphics for the abatement of volatile organic compounds (VOCs), the technology is significantly more energy-efficient than competing thermal oxidation processes, enabling lower manufacturing costs. When integrated into the BTU Tritan™ metallization firing system, it is expected to offer lower cost of ownership and ultimately lower cost per watt for solar cells.

“We are excited to offer leading-edge technology from DuPont with our Tritan firing furnace,” said Jan-Paul van Maaren, Ph. D., vice president of marketing at BTU. “Catalytic oxidation of VOCs promises to use dramatically less power than traditional thermal oxidation. Not only does this impact the tool’s overall cost of ownership and therefore cost per watt, but it also is a more responsible way for our solar customers to manage their effluent.”

“The catalytic oxidation technology was developed for DuPont flexographic printing systems and is well proven with nearly 150 units installed,” said Dalen Keys -- global technology manager, DuPont Packaging Graphics. “We are very pleased to leverage the technology to benefit BTU and the solar energy industry, as we share a commitment to innovation and greater sustainability.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.